Literature DB >> 30607588

The reproductive prognosis of women considering fertility preservation for early stage endometrial cancer.

Pietro Gambadauro1,2,3.   

Abstract

Entities:  

Keywords:  Assisted reproductive technologies; Endometrial cancer; Fertility preservation; Hysteroscopy; Infertility; Progestins

Mesh：

Year:  2019        PMID： 30607588     DOI： 10.1007/s00404-018-5028-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


× No keyword cloud information.
  3 in total

1.  Conservative management of endometrial cancer: a survey amongst European clinicians.

Authors:  M La Russa; I Zapardiel; M J Halaska; K Zalewski; R Laky; P Dursun; D Lindquist; V Sukhin; S Polterauer; I Biliatis
Journal:  Arch Gynecol Obstet       Date:  2018-06-26       Impact factor: 2.344

Review 2.  The basic fertility workup in women with polycystic ovary syndrome: a systematic review.

Authors:  Marleen J Nahuis; G Jurjen E Oosterhuis; Peter G A Hompes; Madelon van Wely; Ben Willem J Mol; Fulco van der Veen
Journal:  Fertil Steril       Date:  2013-04-12       Impact factor: 7.329

3.  Endometrial cancer in a woman undergoing hysteroscopy for recurrent IVF failure.

Authors:  Pietro Gambadauro; Johannes Gudmundsson
Journal:  Gynecol Surg       Date:  2017-04-25
  3 in total
  2 in total

1.  National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.

Authors:  Ross F Harrison; Weiguo He; Shuangshuang Fu; Hui Zhao; Charlotte C Sun; Rudy S Suidan; Terri L Woodard; J Alejandro Rauh-Hain; Shannon N Westin; Sharon H Giordano; Larissa A Meyer
Journal:  Am J Obstet Gynecol       Date:  2019-05-22       Impact factor: 8.661

2.  Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.

Authors:  Erica Herrera Cappelletti; Jonas Humann; Rafael Torrejón; Pietro Gambadauro
Journal:  Hum Reprod Update       Date:  2022-02-28       Impact factor: 15.610
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.